LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | Chief Executive Officer | Mar 25, 2024 | Option Exercise | $57.39 | 16,015 | 919,147 | 120,160 | Mar 27, 2024, 05:47 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | Mar 05, 2024 | Sale | $74.30 | 1,893 | 140,650 | 28,926 | Mar 07, 2024, 01:27 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Director | Mar 05, 2024 | Option Exercise | $39.35 | 2,893 | 113,840 | 74,422 | Mar 06, 2024, 05:28 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 28, 2024 | Option Exercise | $59.79 | 1,404 | 83,949 | 29,895 | Feb 29, 2024, 06:50 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CHIEF LEGAL OFFICER & | Feb 15, 2024 | Option Exercise | $74.65 | 593 | 44,267 | 14,997 | Feb 16, 2024, 08:10 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | PRESIDENT & CHIEF OPERATING | Feb 15, 2024 | Option Exercise | $74.65 | 4,778 | 356,678 | 89,445 | Feb 16, 2024, 08:10 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 15, 2024 | Option Exercise | $74.65 | 1,479 | 110,407 | 21,423 | Feb 16, 2024, 08:10 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | CHIEF EXECUTIVE OFFICER | Feb 15, 2024 | Option Exercise | $74.65 | 1,381 | 103,092 | 71,709 | Feb 16, 2024, 08:10 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | PRESIDENT & CHIEF OPERATING | Jan 02, 2024 | Option Exercise | $72.31 | 2,917 | 210,928 | 94,223 | Jan 04, 2024, 04:07 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CHIEF LEGAL OFFICER & | Dec 29, 2023 | Option Exercise | $60.71 | 179 | 10,867 | 15,590 | Jan 04, 2024, 04:07 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Dec 05, 2023 | Option Exercise | $59.61 | 1,269 | 75,645 | 22,902 | Dec 06, 2023, 03:27 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | PRESIDENT & CHIEF OPERATING | Dec 05, 2023 | Option Exercise | $59.61 | 1,984 | 118,266 | 97,140 | Dec 06, 2023, 03:27 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Oct 01, 2023 | Option Exercise | $59.92 | 346 | 20,732 | 24,171 | Oct 03, 2023, 04:36 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | CHIEF EXECUTIVE OFFICER | Sep 22, 2023 | Buy | $59.38 | 4,000 | 237,529 | 73,090 | Sep 25, 2023, 04:44 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Reardon Andrew | CHIEF LEGAL OFFICER & | Aug 10, 2023 | Option Exercise | $68.73 | 897 | 61,651 | 15,411 | Aug 14, 2023, 04:20 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | PRESIDENT & CHIEF OPERATING | Jun 30, 2023 | Option Exercise | $56.78 | 376 | 21,349 | 99,124 | Jul 10, 2023, 06:42 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $56.78 | 375 | 21,292 | 24,517 | Jul 10, 2023, 06:42 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | CHIEF EXECUTIVE OFFICER | Jun 09, 2023 | Option Exercise | $73.76 | 420 | 30,979 | 69,090 | Jun 13, 2023, 06:52 PM |
LGND | | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | May 16, 2023 | Sale | $77.20 | 4,444 | 343,081 | 38,488 | May 18, 2023, 05:18 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | May 10, 2023 | Sale | $77.13 | 6,408 | 494,225 | 25,784 | May 12, 2023, 03:43 PM |
LGND | | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | May 08, 2023 | Sale | $47.69 | 12,816 | 611,226 | 48,621 | May 10, 2023, 07:15 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Reardon Andrew | See Remarks | Mar 24, 2023 | Sale | $69.92 | 300 | 20,977 | 16,308 | Mar 28, 2023, 05:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | Feb 15, 2023 | Option Exercise | $72.98 | 2,890 | 210,912 | 89,679 | Feb 17, 2023, 07:23 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $72.98 | 849 | 61,960 | 18,096 | Feb 17, 2023, 07:20 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Dec 30, 2022 | Option Exercise | $56.78 | 275 | 15,614 | 18,945 | Jan 04, 2023, 05:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | Dec 28, 2022 | Option Exercise | $66.29 | 3,859 | 255,813 | 92,569 | Dec 30, 2022, 05:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Director | Dec 28, 2022 | Option Exercise | $66.29 | 5,289 | 350,608 | 417,695 | Dec 30, 2022, 05:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Director | Dec 16, 2022 | Sale | $61.87 | 10,000 | 618,657 | 422,984 | Dec 20, 2022, 06:36 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Director | Dec 12, 2022 | Option Exercise | $21.35 | 23,944 | 511,171 | 436,928 | Dec 14, 2022, 05:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | President & COO | Nov 30, 2022 | Option Exercise | $72.90 | 3,593 | 261,930 | 82,428 | Dec 01, 2022, 09:42 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Nov 30, 2022 | Option Exercise | $72.90 | 9,803 | 714,639 | 416,928 | Dec 01, 2022, 09:42 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Nov 30, 2022 | Option Exercise | $72.90 | 1,187 | 86,532 | 7,670 | Dec 01, 2022, 09:41 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Reardon Andrew | See Remarks | Nov 30, 2022 | Option Exercise | $72.90 | 1,073 | 78,222 | 10,940 | Dec 01, 2022, 09:39 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Nov 17, 2022 | Sale | $78.32 | 10,000 | 783,173 | 416,731 | Nov 21, 2022, 07:04 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Nov 18, 2022 | Option Exercise | $12.78 | 10,000 | 127,800 | 426,731 | Nov 21, 2022, 07:04 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Espinoza Octavio | Chief Financial Officer | Nov 09, 2022 | Sale | $75.64 | 1,696 | 128,283 | 8,857 | Nov 10, 2022, 04:30 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Sep 16, 2022 | Sale | $88.06 | 1,000 | 88,060 | 366,180 | Sep 22, 2022, 08:32 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Sep 15, 2022 | Sale | $90.00 | 2,000 | 180,000 | 367,180 | Sep 16, 2022, 07:49 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Sep 16, 2022 | Sale | $89.35 | 3,000 | 268,050 | 364,180 | Sep 16, 2022, 07:49 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Jun 30, 2022 | Option Exercise | $75.84 | 164 | 12,437 | 52,532 | Jul 06, 2022, 08:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $75.84 | 164 | 12,437 | 369,180 | Jul 06, 2022, 08:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | May 13, 2022 | Buy | $82.76 | 2,500 | 206,910 | 173,354 | May 13, 2022, 07:05 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | May 09, 2022 | Option Exercise | $21.92 | 8,000 | 175,360 | 348,593 | May 10, 2022, 05:33 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 15, 2022 | Option Exercise | $123.68 | 3,546 | 438,569 | 173,166 | Feb 16, 2022, 08:24 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Feb 15, 2022 | Option Exercise | $123.68 | 5,923 | 732,557 | 344,570 | Feb 16, 2022, 08:23 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Feb 15, 2022 | Option Exercise | $123.68 | 3,407 | 421,378 | 46,807 | Feb 16, 2022, 08:23 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Jan 26, 2022 | Option Exercise | $113.68 | 3,628 | 412,431 | 50,022 | Jan 28, 2022, 08:43 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Jan 26, 2022 | Option Exercise | $113.68 | 9,243 | 1,050,744 | 355,201 | Jan 28, 2022, 08:42 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Jan 26, 2022 | Option Exercise | $113.68 | 2,156 | 245,094 | 33,298 | Jan 28, 2022, 08:42 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Jan 26, 2022 | Option Exercise | $113.68 | 5,125 | 582,610 | 177,588 | Jan 28, 2022, 08:41 PM |
LGND | | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | Nov 16, 2021 | Option Exercise | $97.08 | 9,670 | 938,749 | 30,233 | Nov 17, 2021, 05:06 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Nov 12, 2021 | Sale | $160.50 | 3,000 | 481,500 | 335,095 | Nov 12, 2021, 07:31 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Nov 11, 2021 | Sale | $92.82 | 23,348 | 2,167,076 | 177,685 | Nov 12, 2021, 04:54 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Aug 04, 2021 | Option Exercise | $67.01 | 18,822 | 1,261,254 | 173,195 | Aug 05, 2021, 04:44 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $85.91 | 247 | 21,220 | 338,095 | Jul 02, 2021, 05:14 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Jun 30, 2021 | Option Exercise | $85.91 | 247 | 21,220 | 39,690 | Jul 02, 2021, 05:13 PM |
LGND | | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | May 11, 2021 | Option Exercise | $18.98 | 5,226 | 99,197 | 34,543 | May 13, 2021, 08:57 PM |
LGND | | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | Feb 22, 2021 | Option Exercise | $10.12 | 2,500 | 25,300 | 29,708 | Feb 23, 2021, 05:18 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Feb 15, 2021 | Option Exercise | $172.46 | 1,015 | 175,047 | 28,701 | Feb 18, 2021, 06:28 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 15, 2021 | Option Exercise | $172.46 | 3,098 | 534,281 | 167,557 | Feb 18, 2021, 06:28 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Feb 15, 2021 | Option Exercise | $172.46 | 5,212 | 898,862 | 341,856 | Feb 18, 2021, 06:27 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Feb 15, 2021 | Option Exercise | $172.46 | 2,309 | 398,210 | 41,318 | Feb 18, 2021, 06:27 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | Director | Feb 10, 2021 | Sale | $213.14 | 5,083 | 1,083,411 | 47,678 | Feb 12, 2021, 06:23 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | Director | Feb 11, 2021 | Option Exercise | $195.91 | 2,474 | 484,681 | 50,152 | Feb 12, 2021, 06:23 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Sabba Stephen L | Director | Feb 09, 2021 | Sale | $109.93 | 29,340 | 3,225,260 | 39,101 | Feb 11, 2021, 04:06 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Feb 05, 2021 | Option Exercise | $76.12 | 172,302 | 13,116,245 | 346,030 | Feb 09, 2021, 06:08 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Feb 04, 2021 | Sale | $178.50 | 18,097 | 3,230,369 | 28,906 | Feb 05, 2021, 05:03 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 04, 2021 | Option Exercise | $99.11 | 90,094 | 8,929,473 | 212,745 | Feb 05, 2021, 05:03 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Jan 25, 2021 | Option Exercise | $91.53 | 107,441 | 9,834,370 | 285,310 | Jan 27, 2021, 07:04 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Jan 27, 2021 | Option Exercise | $77.42 | 110,000 | 8,516,400 | 283,422 | Jan 27, 2021, 07:04 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Jan 25, 2021 | Option Exercise | $156.01 | 3,325 | 518,733 | 160,603 | Jan 27, 2021, 07:03 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Jan 25, 2021 | Option Exercise | $156.01 | 2,111 | 329,337 | 30,933 | Jan 27, 2021, 07:03 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Jan 25, 2021 | Option Exercise | $156.04 | 1,339 | 208,943 | 43,512 | Jan 27, 2021, 07:02 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Davis Todd C | Director | Jan 27, 2021 | Option Exercise | $113.50 | 2,456 | 278,756 | 52,761 | Jan 27, 2021, 07:02 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Dec 31, 2020 | Option Exercise | $84.53 | 223 | 18,851 | 235,310 | Jan 05, 2021, 08:30 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Dec 08, 2020 | Option Exercise | $18.03 | 16,340 | 294,599 | 236,770 | Dec 09, 2020, 06:12 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Nov 09, 2020 | Option Exercise | $17.90 | 22,458 | 401,991 | 224,571 | Nov 10, 2020, 07:41 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Patel Sunil | Director | Nov 02, 2020 | Buy | $82.52 | 1,000 | 82,520 | 28,190 | Nov 04, 2020, 04:19 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Aug 21, 2020 | Option Exercise | $64.23 | 15,240 | 978,881 | 162,638 | Aug 25, 2020, 07:10 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Aug 24, 2020 | Option Exercise | $66.40 | 156 | 10,359 | 155,491 | Aug 25, 2020, 07:10 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Jul 07, 2020 | Option Exercise | $70.01 | 4,315 | 302,098 | 204,571 | Jul 09, 2020, 04:28 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Jun 30, 2020 | Option Exercise | $89.03 | 238 | 21,189 | 41,115 | Jul 01, 2020, 08:06 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Jun 30, 2020 | Option Exercise | $89.03 | 238 | 21,189 | 25,936 | Jul 01, 2020, 08:05 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Jun 04, 2020 | Sale | $118.59 | 11,146 | 1,321,771 | 40,877 | Jun 05, 2020, 04:07 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Feb 15, 2019 | Option Exercise | $120.86 | 1,166 | 140,923 | 16,115 | Apr 24, 2020, 07:24 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 15, 2019 | Option Exercise | $120.86 | 2,826 | 341,550 | 124,615 | Apr 24, 2020, 07:23 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Feb 15, 2019 | Option Exercise | $120.86 | 4,917 | 594,269 | 136,981 | Apr 24, 2020, 07:22 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Mar 13, 2020 | Option Exercise | $21.92 | 2,000 | 43,840 | 157,449 | Mar 13, 2020, 06:33 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 27, 2020 | Sale | $57.98 | 16,156 | 936,691 | 160,968 | Feb 27, 2020, 08:35 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Feb 13, 2020 | Option Exercise | $18.04 | 53,134 | 958,586 | 201,739 | Feb 18, 2020, 05:11 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Feb 15, 2020 | Option Exercise | $97.23 | 5,116 | 497,429 | 208,600 | Feb 18, 2020, 05:11 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 14, 2020 | Option Exercise | $55.16 | 14,450 | 797,013 | 163,454 | Feb 18, 2020, 05:09 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 15, 2020 | Option Exercise | $97.23 | 2,486 | 241,714 | 155,360 | Feb 18, 2020, 05:09 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Feb 13, 2020 | Option Exercise | $21.92 | 496 | 10,872 | 148,833 | Feb 18, 2020, 05:09 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Feb 15, 2020 | Option Exercise | $97.23 | 881 | 85,660 | 52,597 | Feb 18, 2020, 05:07 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Korenberg Matthew E | EVP,Finance & Strategy and CFO | Dec 20, 2019 | Option Exercise | $105.87 | 2,114 | 223,809 | 20,016 | Dec 26, 2019, 02:01 PM |
LGND | | LIGAND PHARMACEUTICALS INC | Berkman Charles S | SVP, Gen. Counsel & Secretary | Dec 20, 2019 | Option Exercise | $105.87 | 1,131 | 119,739 | 49,069 | Dec 26, 2019, 02:01 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Dec 20, 2019 | Option Exercise | $105.87 | 3,654 | 386,849 | 148,337 | Dec 26, 2019, 02:01 PM |
LGND | | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | Dec 20, 2019 | Option Exercise | $105.87 | 6,749 | 714,517 | 153,614 | Dec 26, 2019, 02:00 PM |
LGND | | LIGAND PHARMACEUTICALS INC | FOEHR MATTHEW W | President and COO | Nov 12, 2019 | Option Exercise | $21.92 | 1,001 | 21,942 | 144,620 | Nov 13, 2019, 04:07 PM |